{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:29:03Z","timestamp":1785421743912,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with glioblastoma (GB) not only suffer from a life-threatening oncological disease but also present with severe neurological symptoms and high psychosocial distress. The unfavorable prognosis and the early decline in neurological functions and activities of daily living, such as mobility, lead to a significant deterioration in quality of life aspects. The need for palliative care (PC) therefore arises at an early stage and increases as the disease progresses but is often inadequately assessed and treated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center, retrospective study, we investigated prognostic factors, survival outcomes and neuro-oncologically focused primary palliative care (nPPC) as well as specialized palliative care (SPC) interventions. Pearson\u2019s Chi-square test and an univariable and multivariable binary logistic regression analysis were used to test the independence between categorical variables and the correlation between SPC and tumor-specific therapy prior to death. The Kaplan-Meier method and a multivariable Cox regression analysis were performed to estimate the impact of SPC on survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A cohort of 274 patients with GB was investigated, of whom 251 (91.6%) received nPPC and 210 (76.6%) SPC. Patients with SPC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; OR: 0.302; 95% CI: 0.157\u20130.584) and patients with methylation of the\n                      <jats:italic>MGMT<\/jats:italic>\n                      promoter region (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005; OR: 0.375; 95% CI: 0.190\u20130.739) were less likely to receive a tumor-specific therapy in the 30 days prior to death. Median overall survival was 16.9 months (95% CI: 14.5\u201319.3 months) for patients with SPC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009210) vs. 12.9 months (95% CI: 10.8\u201315.1 months) for patients without (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200964) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.100; not significant). The Cox proportional hazards model demonstrated that SPC significantly correlates with longer overall survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017; HR: 0.707; 95% CI: 0.532\u20130.939).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study revealed a broad availability of PC interventions for patients with GB. After adjustment of known prognostic factors, an association between SPC supply and prolonged OS was observed. Utmost efforts should be made to incorporate PC into the care of every patient within a standardized framework. Data on PC in patients with GB is still rare; therefore, further research should be made to improve PC in this highly burdened patient group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-026-01987-4","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:43:03Z","timestamp":1768542183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palliative care interventions and outcome in patients with glioblastoma \u2013 a retrospective, single-center study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lisa-Marie","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Goettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Riemenschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils-Ole","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Proescholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pukrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rechenmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1987_CR1","doi-asserted-by":"crossref","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology 2021; 23(8):1231\u201351. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/34185076\/.","DOI":"10.1093\/neuonc\/noab106"},{"key":"1987_CR2","doi-asserted-by":"crossref","unstructured":"Price M, Ballard CAP, Benedetti JR, Kruchko C, Barnholtz-Sloan JS, Ostrom QT. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018\u20132022. Neuro-oncology. 2025; 27(Supplement_4):iv1-iv66. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/41092086\/","DOI":"10.1093\/neuonc\/noaf194"},{"key":"1987_CR3","doi-asserted-by":"crossref","unstructured":"Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997\u20131003. Available from: URL:. https:\/\/pubmed.ncbi.nlm.nih.gov\/15758010\/","DOI":"10.1056\/NEJMoa043331"},{"issue":"10172","key":"1987_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","volume":"393","author":"U Herrlinger","year":"2019","unstructured":"Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, et al. Lomustine-temozolomide combination therapy versus standard Temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA-09): a randomised, open-label, phase 3 trial. Lancet. 2019;393(10172):678\u201388.","journal-title":"Lancet."},{"key":"1987_CR5","doi-asserted-by":"crossref","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA. 2017; 318(23):2306\u201316. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/29260225\/","DOI":"10.1001\/jama.2017.18718"},{"key":"1987_CR6","doi-asserted-by":"crossref","unstructured":"Armstrong TS, Vera-Bolanos E, Acquaye AA, Gilbert MR, Ladha H, Mendoza T. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms. Neuro-oncology. 2016; 18(2):252\u201360. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/26289592\/","DOI":"10.1093\/neuonc\/nov166"},{"key":"1987_CR7","doi-asserted-by":"crossref","unstructured":"Peeters MCM, Dirven L, Koekkoek JAF, Gortmaker EG, Fritz L, Vos MJ et al. Prediagnostic symptoms and signs of adult glioma: the patients\u2019 view. Journal of neuro-oncology. 2020; 146(2):293\u2013301. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/31894516\/","DOI":"10.1007\/s11060-019-03373-y"},{"key":"1987_CR8","doi-asserted-by":"crossref","unstructured":"Coomans MB, Dirven L, Aaronson NK, Baumert BG, van den Bent M, Bottomley A et al. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status? Neuro-oncology. 2019; 21(11):1447\u201357. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/31682733\/","DOI":"10.1093\/neuonc\/noz118"},{"key":"1987_CR9","doi-asserted-by":"crossref","unstructured":"Lin E, Rosenthal MA, Eastman P, Le BH. Inpatient palliative care consultation for patients with glioblastoma in a tertiary hospital. Internal Medicine Journal. 2013; 43(8):942\u20135. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/23919337\/","DOI":"10.1111\/imj.12211"},{"key":"1987_CR10","doi-asserted-by":"crossref","unstructured":"Sizoo EM, Braam L, Postma TJ, Pasman HRW, Heimans JJ, Klein M et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro-oncology. 2010; 12(11):1162\u20136. Available from: URL: https:\/\/academic.oup.com\/neuro-oncology\/article\/12\/11\/1162\/1136696","DOI":"10.1093\/neuonc\/nop045"},{"key":"1987_CR11","doi-asserted-by":"crossref","unstructured":"Walbert T, Schultz L, Mikkelsen T, Snyder JM, Phillips J, Fortunato JT. Prospective assessment of end-of-life symptoms and quality of life in patients with high-grade glioma. Neurooncol Pract. 2024; 11(6):733\u20139. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/39554791\/","DOI":"10.1093\/nop\/npae056"},{"key":"1987_CR12","doi-asserted-by":"crossref","unstructured":"Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A et al. The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro-oncology. 2013; 15(5):635\u201343. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/23444258\/","DOI":"10.1093\/neuonc\/not009"},{"key":"1987_CR13","doi-asserted-by":"publisher","unstructured":"Bergo E, Lombardi G, Guglieri I, Capovilla E, Pambuku A, Zagone V. Neurocognitive functions and health-related quality of life in glioblastoma patients: a concise review of the literature. European journal of cancer care. 2019; 28(1):e12410. Available from: URL: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/ecc.12410","DOI":"10.1111\/ecc.12410"},{"key":"1987_CR14","doi-asserted-by":"crossref","unstructured":"Halkett GKB, Lobb EA, Rogers MM, Shaw T, Long AP, Wheeler HR et al. Predictors of distress and poorer quality of life in High Grade Glioma patients. Patient education and counseling. 2015; 98(4):525\u201332. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/25638306\/","DOI":"10.1016\/j.pec.2015.01.002"},{"key":"1987_CR15","doi-asserted-by":"publisher","unstructured":"van Oorschot B, Jentschke E, Kessler AF, Wittig A, Kamp M. Dringende Notwendigkeit f\u00fcr strukturiertes Symptom- und Belastungsscreening bei Patienten mit prim\u00e4ren und sekund\u00e4ren Hirntumoren. Onkologie. 2023; 29(11):984\u201390. Available from: URL: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00761-023-01417-7","DOI":"10.1007\/s00761-023-01417-7"},{"issue":"13","key":"1987_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMp1215620","volume":"368","author":"TE Quill","year":"2013","unstructured":"Quill TE, Abernethy AP. Generalist plus specialist palliative care\u2013creating a more sustainable model. N Engl J Med. 2013;368(13):1173\u20135.","journal-title":"N Engl J Med"},{"key":"1987_CR17","doi-asserted-by":"crossref","unstructured":"Rhee JY, Strander S, Podgurski A, Chiu D, Brizzi K, Forst DA. Palliative Care in Neuro-oncology: an Update. Current neurology and neuroscience reports. 2023; 23(11):645\u201356. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/37751050\/","DOI":"10.1007\/s11910-023-01301-2"},{"key":"1987_CR18","doi-asserted-by":"crossref","unstructured":"Harrison DJ, Wu E, Singh R, Ghaith S, Suarez-Meade P, Brown NJ et al. Primary and Specialist Palliative Care in Neurosurgery: A Narrative Review and Bibliometric Analysis of Glioblastoma and Stroke. World neurosurgery. 2023; 180:e250-e257. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/37739173\/","DOI":"10.1016\/j.wneu.2023.09.048"},{"key":"1987_CR19","unstructured":"DGP. Positionspapier der AG Station\u00e4re Versorgung zur aktuellen Entwicklung von Qualit\u00e4t 2011."},{"key":"1987_CR20","doi-asserted-by":"crossref","unstructured":"Gesell D, Hodiamont F, Bausewein C, Koller D. Accessibility to specialist palliative care services in Germany: a geographical network analysis. BMC health services research. 2023; 23(1):786. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/37488579\/","DOI":"10.1186\/s12913-023-09751-7"},{"key":"1987_CR21","unstructured":"Deutsche Gesellschaft f\u00fcr Palliativmedizin e.V. (DGP). Erweiterte S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht heilbaren Krebserkrankung: AWMF Leitlinienregister; 2021 [cited 2024 Jul 12]. Available from: URL: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/128-001OL"},{"key":"1987_CR22","unstructured":"Zertifizierungskommission Onkologische Zentren. Erhebungsbogen f\u00fcr Onkologische Spitzenzentren und Onkologische Zentren: Nationales Zertifizierungsprogramm Krebs. 2023. Available from: URL: https:\/\/www.krebsgesellschaft.de\/zertdokumente.html"},{"key":"1987_CR23","doi-asserted-by":"crossref","unstructured":"Byrne A, Torrens-Burton A, Sivell S, Moraes FY, Bulbeck H, Bernstein M et al. Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers. The Cochrane database of systematic reviews. 2022; 1(1):CD013440. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/34988973\/","DOI":"10.1002\/14651858.CD013440.pub2"},{"key":"1987_CR24","doi-asserted-by":"crossref","unstructured":"Feng C, Wu Y, Gao L, Guo X, Wang Z, Xing B. Publication Landscape Analysis on Gliomas: How Much Has Been Done in the Past 25 Years? Frontiers in Oncology. 2019; 9:1463. Available from: URL: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6988829\/","DOI":"10.3389\/fonc.2019.01463"},{"key":"1987_CR25","doi-asserted-by":"crossref","unstructured":"Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Rud\u00e0 R et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. The Lancet. Oncology. 2017; 18(6):e330-e340. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1470204517303455","DOI":"10.1016\/S1470-2045(17)30345-5"},{"key":"1987_CR26","doi-asserted-by":"crossref","unstructured":"Fink L, van Oorschot B, von Sa\u00df C, Dibu\u00e9 M, Foster M-T, Golla H et al. Palliative care for in-patient malignant glioma patients in Germany. Journal of neuro-oncology. 2024; 167(2):323\u201338. Available from: URL. https:\/\/pubmed.ncbi.nlm.nih.gov\/38506960\/","DOI":"10.1007\/s11060-024-04611-8"},{"issue":"1","key":"1987_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11060-023-04338-y","volume":"163","author":"RC Crooms","year":"2023","unstructured":"Crooms RC, Taylor JW, Jette N, Morgenstern R, Agarwal P, Goldstein NE, et al. Palliative care referral across the disease trajectory in high-grade glioma. J Neurooncol. 2023;163(1):249\u201359.","journal-title":"J Neurooncol"},{"key":"1987_CR28","doi-asserted-by":"crossref","unstructured":"Wu A, Ruiz Col\u00f3n G, Aslakson R, Pollom E, Patel CB. Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review. Cancers. 2021; 13(12). Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/34201260\/","DOI":"10.3390\/cancers13122867"},{"key":"1987_CR29","doi-asserted-by":"crossref","unstructured":"Pando A, Patel AM, Choudhry HS, Eloy JA, Goldstein IM, Liu JK. Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care? World neurosurgery. 2023; 170:e847-e857. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1878875022016953","DOI":"10.1016\/j.wneu.2022.11.143"},{"key":"1987_CR30","doi-asserted-by":"crossref","unstructured":"Wu A, Ugiliweneza B, Wang D, Hsin G, Boakye M, Skirboll S. Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study. Neurooncol Pract. 2022; 9(4):299\u2013309. Available from: URL: https:\/\/academic.oup.com\/nop\/article\/9\/4\/299\/6555764","DOI":"10.1093\/nop\/npac026"},{"key":"1987_CR31","doi-asserted-by":"publisher","unstructured":"Golla H, Nettekoven C, Hellmich M, Appelmann I, Bausewein C, Becker G et al. Early Palliative Care for Patients with Glioblastoma: A randomized phase lll clinical trial (EPCOG). Neuro-oncology 2025. Available from: URL: https:\/\/academic.oup.com\/neuro-oncology\/advance-article\/doi\/https:\/\/doi.org\/10.1093\/neuonc\/noaf230\/8280414?login=false","DOI":"10.1093\/neuonc\/noaf230\/8280414?login=false"},{"key":"1987_CR32","doi-asserted-by":"crossref","unstructured":"Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE et al. Palliative care and end-of-life care in adults with malignant brain tumors. Neuro-oncology. 2023; 25(3):447\u201356. Available from: URL: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10013651\/","DOI":"10.1093\/neuonc\/noac216"},{"key":"1987_CR33","doi-asserted-by":"crossref","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine. 2005; 352(10):987\u201396. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/15758009\/","DOI":"10.1056\/NEJMoa043330"},{"key":"1987_CR34","doi-asserted-by":"crossref","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nature reviews. Clinical oncology. 2021; 18(3):170\u201386. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/33293629\/","DOI":"10.1038\/s41571-020-00447-z"},{"key":"1987_CR35","unstructured":"Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen e.V. (MDS). Begutachtungsanleitung Spezialisierte ambulante Palliativversorgung (SAPV) und station\u00e4re Hospizversorgung: Richtlinie des GKV-Spitzenverbandes nach \u00a7 282 SGB V. 2019. Available from: URL: https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/hospiz_palliativversorgung\/20190213_BGA_SAPV_und_stationare_Hospizversorgung_final.pdf"},{"key":"1987_CR36","doi-asserted-by":"crossref","unstructured":"Kavalieratos D, Corbelli J, Di Zhang, Dionne-Odom JN, Ernecoff NC, Hanmer J et al. Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis. JAMA. 2016; 316(20):2104\u201314. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/27893131\/","DOI":"10.1001\/jama.2016.16840"},{"key":"1987_CR37","doi-asserted-by":"crossref","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al. Early palliative care for patients with metastatic non-small-cell lung cancer. The New England journal of medicine. 2010; 363(8):733\u201342. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/20818875\/","DOI":"10.1056\/NEJMoa1000678"},{"key":"1987_CR38","doi-asserted-by":"crossref","unstructured":"Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z et al. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015; 33(13):1438\u201345. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/25800768\/","DOI":"10.1200\/JCO.2014.58.6362"},{"key":"1987_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npae022","author":"RC Crooms","year":"2024","unstructured":"Crooms RC, Nnemnbeng JF, Taylor JW, Goldstein NE, Gorbenko K, Vickrey BG. Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma. Neuro Oncol Pract. 2024. https:\/\/doi.org\/10.1093\/nop\/npae022.","journal-title":"Neuro Oncol Pract"},{"key":"1987_CR40","doi-asserted-by":"crossref","unstructured":"Creutzfeldt CJ, Robinson MT, Holloway RG. Neurologists as primary palliative care providers: Communication and practice approaches. Neurology. Clinical practice. 2016; 6(1):40\u20138. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/26918202\/","DOI":"10.1212\/CPJ.0000000000000213"},{"key":"1987_CR41","unstructured":"Onkozert. Jahresberichte O. 2025 [cited 2025 Jul 16]. Available from: URL: https:\/\/www.onkozert.de\/info\/jahresberichte\/"},{"key":"1987_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04674-7","author":"AC Lawson McLean","year":"2024","unstructured":"Lawson McLean AC, Lawson McLean A, Ernst T, Forster M-T, Freyschlag C, Gempt J, et al. Benchmarking palliative care practices in neurooncology: a german perspective. J Neurooncol. 2024. https:\/\/doi.org\/10.1007\/s11060-024-04674-7.","journal-title":"J Neurooncol"},{"key":"1987_CR43","doi-asserted-by":"crossref","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Integration of Palliative Care Into Standard Oncology Care. American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. : 2017; 35(1):96\u2013112. Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/28034065\/","DOI":"10.1200\/JCO.2016.70.1474"},{"issue":"11","key":"1987_CR44","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1177\/1049909120983283","volume":"38","author":"J Parajuli","year":"2021","unstructured":"Parajuli J, Hupcey JE. A systematic review on barriers to palliative care in oncology. Am J Hosp Palliat Care. 2021;38(11):1361\u201377.","journal-title":"Am J Hosp Palliat Care"},{"key":"1987_CR45","doi-asserted-by":"crossref","unstructured":"Vierhout M, Daniels M, Mazzotta P, Vlahos J, Mason WP, Bernstein M. The views of patients with brain cancer about palliative care: a qualitative study. Curr Oncol. 2017; 24(6):374\u201382. Available from: URL: https:\/\/www.mdpi.com\/1718-7729\/24\/6\/3712","DOI":"10.3747\/co.24.3712"},{"key":"1987_CR46","doi-asserted-by":"publisher","unstructured":"Kaiser U, Vehling-Kaiser U, K\u00fcck F, Mechie N-C, Hoffmann A, Kaiser F. Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis. BMC palliative care. 2020; 19(1):140. Available from: URL: https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12904-020-00648-4","DOI":"10.1186\/s12904-020-00648-4"},{"key":"1987_CR47","doi-asserted-by":"crossref","unstructured":"Kaiser U, Vehling-Kaiser U, Hoffmann A, Kaiser F. Inpatient Hospices in Germany: Medical Care Situation and Use of Supportive Oncological Therapies for Symptom Control in Tumor Patients. Palliative Medicine Reports. 2022; 3(1):169\u201380. Available from: URL: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9438444\/","DOI":"10.1089\/pmr.2022.0026"},{"key":"1987_CR48","doi-asserted-by":"publisher","unstructured":"Kubendran S, Schockett E, Jackson E, Huynh-Le MP, Roberti F, Rao YJ et al. Trends in inpatient palliative care use for primary brain malignancies. Support Care Cancer. 2021; 29(11):6625\u201332. Available from: URL: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00520-021-06255-0","DOI":"10.1007\/s00520-021-06255-0"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-026-01987-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-01987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-01987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:27:38Z","timestamp":1769509658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12904-026-01987-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1186\/s12904-026-01987-4","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regensburg University Institutional Ethics Review Board (vote no. 24-3606-104) and was conducted in accordance with the Declaration of Helsinki. In accordance with the Regensburg University Institutional Ethics Review Board and local regulations (Bayerisches Universit\u00e4tsklinikagesetz \u2013 BayUniKlinG), informed consent to participate was not necessary due to the retrospective character of this analysis. All study participants had deceased at the time the study was conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}